GlassScriptPhysician profile
Tarik A Ali
NPI 1477068310
$1,417.47
in general payments reported to CMS, 2019-2025
15 companies · $680 in 2025
The $680 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.24 · 2021: $41.67 · 2022: $12.28 · 2023: $413 · 2024: $258 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,351.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $554.52 | 2022-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $417.14 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Exact Sciences Corporation | $169.73 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $56.03 | 2023 | Inspire |
| Axsome Therapeutics, INC. | $32.65 | 2025 | Auvelity |
| Cipher Pharmaceuticals US LLC | $25.78 | 2025 | Natroba, Spinosad |
| Sanofi-Aventis U.S. LLC | $25.35 | 2025 | |
| Medtronic, INC. | $23.31 | 2024 | Interstim |
| Shield Therapeutics INC | $19.85 | 2023 | Accrufer |
| Vivaquant INC, Dba Rhythm Express | $19.16 | 2025 | Rhythm Express |
| Cranial Technologies, INC | $17.67 | 2025 | Doc Band |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.33 | 2021 | |
| Lilly USA, LLC | $14.58 | 2024 | Mounjaro |
| Merck Sharp & Dohme LLC | $12.24 | 2019 | |
| Dexcom, INC. | $12.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarik Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.